Moderna | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Agios Pharmaceuticals USD -105399000 1.11B 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
Amgen USD 3.38B 111M 2024-12
Arrowhead Research USD -175115000 2.32M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Celltrion KRW 273.99B 95.74B 2024-12
Cspc Pharmaceutical CNY 944.38M 798.51M 2024-09
Dianthus Therapeutics USD -28440000 3.27M 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 563M 2.08B 2024-12
Incyte USD 406.83M 147.12M 2024-12
Ionis Pharmaceuticals USD -107000000 37M 2024-12
Kangmei Pharma -5720000 15.38M 2024-09
Knight Therapeutics CAD -7144000 19.01M 2024-03
Laboratorios Farma 121.55M 84.42M 2024-12
Moderna USD -1184000000 1.2B 2024-12
Organigram Holdings CAD -22957000 4.15M 2024-12
Pharma Mar EUR 9.54M 5.66M 2024-12
Qiagen NV USD 169.1M 52.64M 2024-12
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
Sartorius EUR 99.5M 69.5M 2025-03
Tilray USD -83239000 49.47M 2024-11
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 396.5M 7.9M 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Zz Pientze Pharmaceu 1.13B 234.17M 2024-09



Moderna Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.